rs1363308293
Variant summary
Our verdict is Likely pathogenic. The variant received 8 ACMG points: 8P and 0B. PM2PM5PP3_ModeratePP5_Moderate
The NM_006517.5(SLC16A2):c.1390C>A(p.Pro464Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P464S) has been classified as Likely pathogenic.
Frequency
Consequence
NM_006517.5 missense
Scores
Clinical Significance
Conservation
Publications
- Allan-Herndon-Dudley syndromeInheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, ClinGen, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 8 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SLC16A2 | NM_006517.5 | c.1390C>A | p.Pro464Thr | missense_variant | Exon 5 of 6 | ENST00000587091.6 | NP_006508.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SLC16A2 | ENST00000587091.6 | c.1390C>A | p.Pro464Thr | missense_variant | Exon 5 of 6 | 1 | NM_006517.5 | ENSP00000465734.1 | ||
| SLC16A2 | ENST00000636771.1 | n.*1091C>A | non_coding_transcript_exon_variant | Exon 6 of 7 | 5 | ENSP00000490445.1 | ||||
| SLC16A2 | ENST00000636771.1 | n.*1091C>A | 3_prime_UTR_variant | Exon 6 of 7 | 5 | ENSP00000490445.1 | ||||
| SLC16A2 | ENST00000590447.1 | c.610-1901C>A | intron_variant | Intron 3 of 3 | 5 | ENSP00000466213.1 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome Cov.: 29
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
Allan-Herndon-Dudley syndrome Pathogenic:1
Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Likely pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with Allan-Herndon-Dudley syndrome (MIM#300523). (I) 0109 - This gene is associated with X-linked recessive disease. Hemizygous males and homozygous females are known to be affected with the full range of symptoms associated with Allan-Herndon-Dudley syndrome while some heterozygous females develop a mild thyroid phenotype but no neurological symptoms (OMIM). (I) 0200 - Variant is predicted to result in a missense amino acid change from proline to threonine. (I) 0253 - This variant is hemizygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0502 - Missense variant with conflicting in silico predictions and uninformative conservation. (I) 0603 - Missense variant in a region that is highly intolerant to missense variation (high constraint region in DECIPHER). (SP) 0703 - Another missense variant and inframe deletion comparable to the one identified in this case has moderate previous evidence for pathogenicity. These variants (p.(Pro464del)) and p.(Pro464Ser) have each been seen in one individual with Allan-Herndon-Dudley syndrome (PMID:27081503, 32277047). (SP) 0807 - This variant has no previous evidence of pathogenicity. (I) 0903 - This variant has limited evidence for segregation with disease. It has been found in two similarly affected hemizygous maternal great uncles. (SP) 1005 - Clinically accredited laboratory assay specific to gene product shows abnormal protein function. This individual has been found to have increased free triiodothyronin (FT3). (SP) 1205 - This variant has been shown to be maternally inherited (by trio analysis). (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at